NPORT-EX 2 MIMA700MATT093021.htm FOR VALIDATION PURPOSES ONLY - [239746.TXG]
Matthews Asia Growth Fund    September 30, 2021

Schedule of Investmentsa (unaudited)

COMMON EQUITIES: 100.4%

 

     Shares     Value  
CHINA/HONG KONG: 39.5%    

Wuxi Biologics Cayman, Inc.b,c,d

    8,421,500       $136,599,222  

BeiGene, Ltd. ADRc

    224,200       81,384,600  

Innovent Biologics, Inc.b,c,d

    6,984,500       67,262,494  

Bilibili, Inc. ADRc

    904,800       59,870,616  

XPeng, Inc. ADRc

    1,442,975       51,283,331  

Silergy Corp.

     345,000       50,181,482  

Shenzhen Inovance Technology Co., Ltd. A Shares

     4,225,612       41,158,929  

InnoCare Pharma, Ltd.b,c,d

    13,816,000       37,003,260  

Shenzhou International Group Holdings, Ltd.

     1,490,400       31,631,462  

Meituan B Sharesb,c,d

    915,100       29,211,319  

RemeGen Co., Ltd. H Sharesb,c,d

    2,290,000       28,806,922  

WuXi AppTec Co., Ltd. A Shares

     1,192,836       28,186,960  

Burning Rock Biotech, Ltd. ADRc

    1,528,948       27,337,590  

Hangzhou Tigermed Consulting Co., Ltd. H Sharesb,d

    1,284,600       27,164,096  

Alibaba Group Holding, Ltd.c

    1,173,600       21,727,961  

Jacobio Pharmaceuticals Group Co., Ltd.b,c,d

    8,477,400       20,224,756  

Shimao Services Holdings, Ltd.b,d

    9,452,000       19,542,255  

AK Medical Holdings, Ltd.b,d

    11,702,000       16,190,689  

Medlive Technology Co., Ltd.b,c,d

    3,338,500       16,146,458  

Peijia Medical, Ltd.b,c,d

    5,343,000       13,965,892  

JD Health International, Inc.b,c,d

    1,437,400       13,852,321  

Adagene, Inc. ADRc

    753,700       10,928,650  

Kindstar Globalgene Technology, Inc.b,c,d

     7,212,500       5,521,957  

Zhaoke Ophthalmology, Ltd.b,c,d

    5,683,633       5,447,280  
   

 

 

  

Total China/Hong Kong

       840,630,502  
   

 

 

  
   
     
JAPAN: 31.8%    

Sony Group Corp.

     770,900       85,584,356  

Nintendo Co., Ltd.

     109,500       52,328,173  

Terumo Corp.

     921,900       43,530,622  

Daiichi Sankyo Co., Ltd.

     1,302,500       34,621,973  

Sansan, Inc.c

    348,400       33,595,084  

Keyence Corp.

     55,500       33,126,347  

Shin-Etsu Chemical Co., Ltd.

     193,200       32,606,160  

Nidec Corp.

     289,200       31,881,410  

M3, Inc.

     400,400       28,535,835  

Advantest Corp.

     315,300       28,096,233  

Sysmex Corp.

     214,800       26,679,999  

OBIC Business Consultants Co., Ltd.

     518,100       26,375,429  

Appier Group, Inc.c

    1,805,100       23,109,858  

Toyota Motor Corp.

     1,229,000       21,897,568  

SoftBank Group Corp.

     376,100       21,733,046  

HEALIOS KKc

    1,243,200       21,663,032  

GMO Payment Gateway, Inc.

     160,100       20,214,470  

Eisai Co., Ltd.

     261,800       19,610,779  

Japan Elevator Service Holdings Co., Ltd.

     805,200       18,516,447  

PeptiDream, Inc.c

    555,300       18,127,352  

Freee KKc

    218,700       15,913,878  

Nitori Holdings Co., Ltd.

     66,900       13,184,112  

Hikari Tsushin, Inc.

     60,900       10,293,255  

Sosei Group Corp.c

    550,900       9,351,269  

Simplex Holdings, Inc.c

    440,700       7,982,849  
   

 

 

  

Total Japan

       678,559,536  
   

 

 

  
   
     Shares     Value  
INDIA: 15.0%    

Bajaj Finance, Ltd.

     655,186       $67,417,596  

HDFC Bank, Ltd.

     2,837,251       60,655,485  

Reliance Industries, Ltd.

     1,361,517       46,080,286  

Avenue Supermarts, Ltd.b,c,d

    789,988       45,094,696  

Dabur India, Ltd.

     3,753,077       31,142,366  

Maruti Suzuki India, Ltd.

     288,627       28,468,384  

Crompton Greaves Consumer Electricals, Ltd.

     2,903,361       18,706,700  

Dr. Lal PathLabs, Ltd.b,d

    272,658       13,460,309  

Zomato, Ltd.c

    4,417,678       8,129,801  
   

 

 

  

Total India

       319,155,623  
   

 

 

  
   
     
UNITED STATES: 3.7%    

Legend Biotech Corp. ADRc

    771,938       39,029,185  

Schrodinger, Inc.c

    392,000       21,434,560  

Terns Pharmaceuticals, Inc.c

    875,068       9,118,209  

Turning Point Therapeutics, Inc.c

     135,900       9,027,837  
   

 

 

  

Total United States

       78,609,791  
   

 

 

  
   
     
AUSTRALIA: 2.7%    

CSL, Ltd.

     278,623       58,213,059  
   

 

 

  

Total Australia

       58,213,059  
   

 

 

  
   
     
SINGAPORE: 2.6%    

Sea, Ltd. ADRc

    173,100       55,172,163  
   

 

 

  

Total Singapore

       55,172,163  
   

 

 

  
   
     
TAIWAN: 2.0%    

Taiwan Semiconductor Manufacturing Co., Ltd. ADR

     389,800       43,521,170  
   

 

 

  

Total Taiwan

       43,521,170  
   

 

 

  
   
     
INDONESIA: 1.9%    

PT Bank Rakyat Indonesia Persero

     127,302,300       33,932,018  

PT Mayora Indah

     41,835,900       6,886,808  
   

 

 

  

Total Indonesia

       40,818,826  
   

 

 

  
   
     
VIETNAM: 0.7%    

Vietnam Dairy Products JSC

     3,739,910       14,689,871  
   

 

 

  

Total Vietnam

       14,689,871  
   

 

 

  
   
     
NEW ZEALAND: 0.5%    

Xero, Ltd.c

    100,404       9,852,499  
   

 

 

  

Total New Zealand

       9,852,499  
   

 

 

  
   
     
TOTAL INVESTMENTS: 100.4%       2,139,223,040  

(Cost $1,494,059,595)

    
   
LIABILITIES IN EXCESS OF CASH
AND OTHER ASSETS: (0.4%)		       (8,807,242 ) 
   

 

 

  

NET ASSETS: 100.0%

       $2,130,415,798  
   

 

 

  
 

 

     matthewsasia.com  |  800.789.ASIA      1  
Matthews Asia Growth Fund    September 30, 2021

Schedule of Investmentsa (unaudited) (continued)

 

a

Certain securities were fair valued under the valuation policies approved by the Board of Trustees.

 

b

Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. The security may be resold in transactions exempt from registration normally to qualified institutional buyers. The security has been determined to be liquid in accordance with procedures adopted by the Funds’ Board of Trustees. At September 30, 2021, the aggregate value is $495,493,926, which is 23.26% of net assets.

 

c

Non-income producing security.

 

d

The securities may be resold to qualified foreign investors and foreign institutional buyers under Regulation S of the Securities Act of 1933.

 

ADR

American Depositary Receipt

 

JSC

Joint Stock Co.

Other information regarding the Fund is available in the Funds’ most recent report to shareholders. This information is available on the Securities and Exchange Commission’s website (www.sec.gov).

 

 

2    MATTHEWS ASIA FUNDS